Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development-Reference-Cited by-同舟云学术

Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development

Published:2018-05-28 Issue:6 Volume:19 Page:1591
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Sgrignani Jacopo^ORCID,Garofalo Maura,Matkovic Milos,Merulla Jessica,Catapano Carlo V.,Cavalli Andrea

Funder

Krebsliga Schweiz

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/6/1591/pdf

Reference100 articles.

1. Transcription factors as targets for cancer therapy

2. Heterodimeric JAK–STAT activation as a mechanism of persistence to JAK2 inhibitor therapy

3. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

4. STATs: transcriptional control and biological impact

5. Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation;Experimental & Molecular Medicine;2024-09-02

2. Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer;Heliyon;2024-09

3. Feasibility of the inhibitor development for cancer: A systematic approach for drug design;PLOS ONE;2024-08-22

4. Macrophage dynamics in prostate cancer: Molecular to therapeutic insights;Biomedicine & Pharmacotherapy;2024-08

5. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08